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Abstract
The number of cases of pregnant patients with cardiorespiratory arrest requiring 
resuscitation has increased worldwide, secondary to the main number of patients 
with high-risk pregnancies associated with chronic, especially cardiopulmonary, 
pathologies. The knowledge of the resuscitation algorithms by the health personnel 
responsible for the care of pregnant patients is mandatory, because due to different 
physiological and anatomical changes, there are particularities in the management 
and use of medications. In addition, a detailed description of the steps included in 
the resuscitation is necessary, where assessment of the airway, ventilation, circula-
tion, and defibrillation determines a step in resuscitation. One of the determining and 
exclusive events in this type of patients is cesarea perimortem. That is why it includes 
a concrete description of the time and the indications for its realization. Finally, a 
list of medicines most used in resuscitation in pregnancy, with its dosage and safety 
range, is mentioned. The pregnant patient poses a challenge to resuscitation teams. 
This review refers to the recommendations for establishing “obstetric blue code” pro-
tocols at the institutional level.
Keywords: reanimation, maternal arrest, pregnancy, cardiopulmonary, perimortem 
caesarean
1. Introduction
The approach to resuscitation in pregnancy determines several conditions that go from the 
physiological, anatomical, and emotional point of view, as we face a catastrophic event and 
the challenge of restoring the health condition of two living beings as a mother [1]. Knowledge 
and training in resuscitation of the obstetric patient has had a great development in the last 
decade, with an increasing number of publications and special chapters in the international 
guides of resuscitation [2].
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Although maternal mortality worldwide has declined by 44%, there has been a worrying 
increase in extreme maternal morbidity and mortality in developed countries around the 
world due to increased pregnancy age and comorbidities that determine a greater number of 
situations of cardiac arrest [3].
In the USA, the prevalence of events requiring cardiac resuscitation in hospitalized obstetric 
patients was 8.5 × 100,000, with a survival rate of only 59% in the mother [4].
We believe that the scope of this chapter includes the knowledge of the various groups respon-
sible for mother–child resuscitation, such as emergency physicians, obstetricians, anesthesi-
ologists, critical care physicians, and neonatologists, as well as nurses and midwives.
2. Changes physiologic in the mother
The physiological and anatomical changes of pregnancy require some modifications in the 
resuscitation protocols, these changes begin early in pregnancy, reach their peak during the 
second trimester, and then, remain relatively constant until delivery.
The major hemodynamic changes induced by pregnancy include an increase in cardiac output 
between 30 and 40% (as a result of increased stroke volume and to a lesser extent increased 
maternal heart rate 15–20 bpm) [5], plasma volume expansion is 10–15% at 6–12 weeks of 
gestation, and at the term, is 30–50% higher than non-pregnant women, increase in red cell 
volume [6] (a greater increase in intravascular volume than red cell mass, that results in the 
dilutional or physiologic anemia of pregnancy), reductions in systemic vascular resistance 
and systemic blood pressure [7].
Most of the increase in cardiac output is distributed in the placenta, kidneys, and skin so 
that the mechanical effects of the gravid uterus can decrease venous return from the inferior 
vena cava and obstruct blood flow through the abdominal aorta; all of above, contribute to 
unsuccessful cardiopulmonary resuscitation. Left lateral uterine displacement is necessary 
in the pregnant patient with fundal height at or above the umbilicus, to minimize aortocaval 
compression, to optimize venous return, and to generate adequate stroke volume during car-
diopulmonary resuscitation [6].
During pregnancy, the anatomy of the upper respiratory airway undergoes numerous 
changes; upper airway, the pharynx and larynx edema occur as a result of hormonal effects 
and may reduce visualization during laryngoscopy and therefore, intubation in a pregnant 
woman can be difficult, and smaller endotracheal tubes may be needed [6, 8].. Therefore, pro-
gesterone relaxes gastroesophageal sphincters and prolongs transit times throughout the 
intestinal tract, predisposing the patient to aspiration of stomach contents [9].
Changes in the thorax and abdomen appear early in pregnancy; even before displacement 
from the enlarging uterus. In the first trimester, the subcostal angle changes from 68 to 103°, 
the diaphragm rises by up to 4 cm and the chest diameter increases by 2 cm or more, dia-
phragmatic excursion increases by up to 2 cm (the result is “barrel chested” appearance) [8].
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Since the first trimester of pregnancy, a relative hyperventilation occurs, with minute ventila-
tion rise by 50% at term, mediated by the elevated serum progesterone levels. This produces a 
mild respiratory alkalosis with compensatory renal excretion of bicarbonate [8].
The functional residual capacity decreases approximately 20% due to the upward shift in 
the diaphragm as the uterus enlarges, while oxygen consumption increases by 20% during 
pregnancy to meet the increased oxygen demands of the placenta, fetus and maternal organs. 
These two factors are responsible for hypoventilation in the pregnant woman [5, 9].
Forced expiratory volume (FEV1) does not change during pregnancy, but expiratory reserve 
volume and residual volume decrease, inspiratory capacity is mildly increased, resulting in a 
minimal drop in the total lung capacity from 4.2 to 4 l, In addition, there is a decrease in arte-
rial carbon dioxide (PaCO
2
) levels from 40 mmHg in non-pregnant to 27–32 mmHg during 
pregnancy, so that, the resultant arterial pH is normal to slightly alkalotic (between 7.40 and 
7.45). The decrease in PaCO
2
 helps the fetus to eliminate carbon dioxide across the placenta [9].
3. Etiology
It is necessary to know the possible etiology of cardiac arrest in pregnant women to iden-
tify and treat correctly the causal factors and therefore give the mother and the fetus a 
better chance of survival. The cause of maternal cardiac arrest can often be multifactorial, 
and in many cases it is associated with chronic health problems that exist before preg-
nancy, so women with comorbidities should have multidisciplinary follow-up. Even so, it 
must be taken into account that cardiorespiratory arrest (CRA) in pregnant women occurs 
frequently in previously healthy woman in relation to hemorrhage or embolism (non-
arrhythmogenic causes, unlike non-pregnant women). This refers to the non-pulsed electri-
cal activity algorithm (AESP) in which the modified 5H and 5T must be remembered (see 
Table 1) [4, 10–15].
5H 5T
1. Hypoxia: particular predisposition that the pregnant 
woman has due to the high consumption of oxygen by 
the developing fetus
1. Toxics/tablets
2. Hypovolemia: uterine atony, placental abruption, 
placenta previa, placenta accreta, subcapsular hepatic 
hematoma, ectopic pregnancy, uterine rupture, retained 
products of conception
2. Thrombosis: pulmonary thrombosis and Coronary 
thrombosis
3. Hydroelectrolitic: hypermagnesemia. Treatment of 
threatened preterm or preeclampsia, particularly in renal 
failure, hyperkalemia/hypokalemia
3. Tension: pneumothorax tension
4. Hydrogenions-acidosis 4. Tamponade: cardiac tamponade.
5. Hypothermia 5. Trauma
Table 1. Etiologies of maternal arrest (5H-5T) [11–15].
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The main causes of CRA in pregnant women include bleeding, heart failure, sepsis, and 
amniotic fluid embolism, and the main causes of mortality in this population are the car-
diac disease, sepsis, preeclampsia/eclampsia, hemorrhage, cerebrovascular events, amni-
otic fluid embolism, complications from anesthesia, and thrombosis/thromboembolism [4, 
10]. A way to remember those causes is the mnemonic of the American Heart Association 
(AHA), because the obstetrics’ CRA causes are different from the general population [5] 
(see Table 2).
Letter Meaning Etiology
A Anesthetic
Accidents
High neuraxial block
Hypotension
Loss of airway
Aspiration
Respiratory depression
Local anesthetic systemic toxicity
Trauma
Suicide
B Bleeding Coagulopathy
Uterine atony
Placenta accreta
Placental abruption
Placenta previa
Retained products of conception
Uterine rupture
Surgical
Transfusion reaction
C Cardiovascular Myocardial infarction
Aortic dissection
Cardiomyopathy
Arrhythmias
Valve disease
Congenital heart disease
D Drugs Oxytocin-magnesium-opioids-insulin
Drug error
Illicit drugs
Anaphylaxis
E Embolic Amniotic fluid embolus
Pulmonary embolus
Cerebrovascular event
Venous air embolism
F Fever Infection/sepsis
G General H’s and T’s (Table 1)
H Hypertension Preeclampsia-eclampsia
HELLP syndrome
Intracranial bleed
Table 2. Etiologies of maternal arrest (A to H’s mnemonic) [5].
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4. Management
The management of CRA in pregnant women should ideally be performed by trained indi-
viduals, with knowledge of the physiological changes in pregnancy, in the centers where the 
equipments necessary for cesarean perimortem and for neonatal resuscitation are available. 
The most important pillar in the management of CRA in pregnant women is prevention [5], 
guaranteeing adequate oxygenation, and circulatory volume, so it is recommended to place 
the patient in a position of complete left lateral decubitus to relieve the aortocava compres-
sion, administration of 100% oxygen by face mask to treat or prevent hypoxemia, establish 
intravenous access above the diaphragm to ensure intravenous therapy is not obstructed by 
the pregnant uterus and to investigate and treat precipitating factors [11]. In the CRA there is 
basic and advanced management, first the basic management of pregnant women in CRA and 
then the advanced management will be discussed, emphasizing the changes with respect to 
the CRA of the non-pregnant adult.
4.1. Basic cardiovascular life support
the basic life support (BLS), the first responders must initiate usual resuscitation measures, 
including board placement, and provision of chest compressions and appropriate airway man-
agement, defibrillation where appropriate, and manual left uterine displacement [12] (algorithm 
N1). A minimum of four responders must be present to carry out all tasks  effectively (Figure 1).
4.1.1. Circulation
Thoracic compressions: the patient should be placed supine for chest compressions (chest com-
pressions performed with the patient in a tilt could be significantly less effective than those 
performed with the patient in the usual supine position, and this could have a major impact 
on the chance of successful resuscitation), which must be effective at least 5 cm deep, are 
performed 3 cm above the traditional sternal point, frequently at least 100 per min and with 
a sequentiality of 30 chest compressions: 2 artificial ventilation, deviation of the uterus to the 
left manually, it is recommended to allow complete thoracic expansion after each compres-
sion and to minimize interruptions in chest compressions. Once a device has been placed 
the compressions can be continuous and not alternate with the ventilation [10–12]. There 
is no literature examining the use of mechanical chest compressions in pregnancy, and this 
is not advised at this time. Previous guidelines recommended placing the hands slightly 
higher on the sternum in the pregnant patient, but there are no scientific data to support this 
recommendation.
4.1.2. Airway
After placing the pregnant woman in a suitable position, the opening of the airway is per-
formed, head extension maneuver is performed, neck flexion and chin elevation (except in 
patients with a history of cervical trauma, in which if only the lower jaw is raised), if there is 
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no response, be prepared to ensure the airway definitively, initiate with pre-oxygenation of 
the patient with 100% FiO
2
, due to the complications in the pregnant patient because of the 
physiological changes of the pregnancy. It is recommended to perform this procedure with 
personnel having greater training in airways, it is recommended to have the “STUBBY” (short-
handled) laryngoscope for mammary hypertrophy, and to have on hand a difficult airway 
equipment with elements such as mask Laryngeal in case conventional intubation is not possi-
ble. It is recommended to make only one attempt and ask for help from the most qualified per-
sonnel, if you are in second or third level of care, request help from the anesthesiology group.
4.1.3. Defibrillation
Identify the defibrillator of your workplace and identify if it is biphasic or monophasic. In the 
absence of a biphasic defibrillator, it is acceptable to use a single-phase, so far has not shown 
any injury to the fetus by defibrillation. Defibrillary Cardiopulmonary Arrest (CPA) Rates: We 
recommend the administration of 200 J by a biphasic defibrillator or 360 J by a single-phase 
defibrillator in ventricular fibrillation and non-pulse ventricular tachycardia, alternating with 
Figure 1. Basic life support (BLS)—cardiac arrest in pregnancy.
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the administration of the following drugs: Adrenaline 1 mg IV every 3 min [10–14]. The energy 
required for defibrillation during cardiac arrest in pregnancy would be the same as the most 
current recommendations for the non-pregnant patient.
5. Advanced cardiovascular life support 
Although current guidelines for management of CPA adults say that chest compressions 
should not be interrupted initially for ventilation or airway placement. The pregnant 
patient has a very limited oxygen reserve and requires early attention to airways and 
ventilation.
In the advanced cardiovascular life support (ACLS), it is recommended that endotracheal 
intubation should be performed by an experienced laryngoscopist (not more than two laryn-
goscopy attempts should be made and prolonged intubation attempts should be avoided to 
prevent deoxygenation, prolonged interruption in chest compressions, airway trauma, and 
bleeding), and starting with an endotracheal tube with a 6.0–7.0 mm inner diameter is recom-
mended, because the glottis in pregnancy is often smaller for edema. The cricoid pressure is 
not routinely recommended, but, continuous waveform capnography, in addition to clinical 
assessment, is recommended as the most reliable method of confirming and monitoring cor-
rect placement of the endotracheal tube (Figure 2).
If attempts at airway control fail and mask ventilation is not possible, current guidelines for 
emergency invasive airway should be followed.
Given the lethality of cardiopulmonary arrest, the benefits from use outweigh any possible 
fetal risks. All medications at the same doses for treatment of cardiopulmonary arrest in the 
non-pregnant patient are used for the pregnant patient (Table 3).
5.1. Arrhythmia-specific therapy during cardiac arrest
5.1.1. Cardiopulmonary non-defibrillation rhythms
In case of asystole and pulseless electrical activity, focus on chest compressions as well as 
drug administration. Other potentially lethal arrhythmias that should be treated.
5.1.2. Ventricular tachycardia with pulse 
Stable monomorphic VT with adult pulse responds well to biphasic or monophasic (synchro-
nized) cardioversion discharges at initial doses of 100 J. If there is no adequate response after 
the first discharge, it is reasonable to increase the dose in a staggered manner.
5.1.3. Supraventricular paroxysmal tachycardia 
In addition to synchronous cardioversion, adenosine is also recommended as a safe and 
potentially effective drug. There are no data yet on pregnancy. The recommended initial 
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Medications Use Adverse effects Observations Dose
Epinephrine If VF or VT persists 
after at least one 
attempt at defibrillation 
and 2 min of CPA
Reduce uterine blood flow 
through alpha-adrenergic-
mediated blood vessel 
vasoconstriction
Is superior 1 mg IV every 3–5 
min
Vasopressin Was removed from the 
treatment algorithm 
for CPA
Uterine contractions Is not clearly superior 
to epinephrine
Is not 
recommended
Magnesium 
sulfate
Pregnancy
• Prevention of 
eclamptic seizures
• Fetal neuroprotec-
tion before preterm 
delivery
Magnesium toxicity Should be 
discontinued
Calcium chloride (10 
mL of a 10% solution) 
or calcium gluconate 
(30 mL of a 10% 
solution) intravenously 
or intraosseously
4 or 6 g IV, 
followed by a 
maintenance 1–2 
g IV/h
Figure 2. Advanced cardiovascular life support (ACLS)—cardiac arrest in pregnancy.
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biphasic energy dose for synchronous cardioversion of atrial fibrillation is 120–200 J. The ini-
tial monophasic dose for synchronous cardioversion of atrial fibrillation is 200 J. In general, 
atrial flutter cardioversion and other supraventricular rhythms require less energy. An initial 
energy of 50–100 J with a single-phase or biphasic device is usually sufficient. If the first dis-
charge of the cardioversion fails, the dose should be increased stepwise.
6. Modifications of the basic support and advanced cardiac life support in 
pregnancy
The three major modifications during the pregnant patient CPR are given in below sections.
6.1. Shift of the uterus to the left at 15–30° and upward during chest compressions 
To improve placental perfusion and enable a perimortem cesarean, it has been described 
that thoracic compressions in non-pregnant patients produce 30% of the CG, to which 25% 
more is added by applying the lateralization of the uterus to the left. For this purpose, a 
blanket can be placed under the right hip or the Cardiff resuscitation wedge, which main-
tains the patient in the left dorsal decubitus position at 27° since an inclination greater 
than 30° has been associated with a significant decrease in force generation during chest 
compression.
Medications Use Adverse effects Observations Dose
CPA • Polymorphic VT 
consistent with 
torsade de pointes
Is not recommended 
for routine use in adult 
cardiac arrest patients
2 g IV, followed 
by a maintenance 
infusion
Sodium 
bicarbonate
Correction of maternal 
acidosis
May worsen fetal acidosis
Since crosses the placenta, 
overcorrection of maternal 
acidosis will lead to pooling 
of carbon dioxide in the 
fetal compartment
Guidelines do not 
recommend routine 
use
Useful in life-
threatening 
hyperkalemia or 
tricyclic antidepressant 
overdose
1–2 mEq/kg IV
Amiodarone Primary drug in the 
arrhythmia treatment 
algorithm
VF or VT unresponsive 
to defibrillation, CPA, 
and epinephrine
• Hypothyroidism or 
hyperthyroidism in 
the mother or fetus 
because of the iodine in 
amiodarone
• Fetal bradycardia
• Fetal QT interval 
prolongation
• Premature labor
• Low birth weight
Neonates of mothers 
taking amiodarone 
should have complete 
thyroid function tests 
and developmental 
follow-up
300 mg IV with 
a repeat dose 
of 150 mg IV as 
indicated
Table 3. Medications used in CPA and its consequences in pregnancy.
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6.2. Early endotracheal intubation 
Waive ventilation with bag-mask and proceed directly to endotracheal intubation by the most 
experienced person, as the physiological changes of pregnancy increase 10 times the risk of com-
plications they put. It is life-threatening mainly because of decreased functional residual capacity 
(CRF) by compression of the pregnant uterus, resulting in rapid desaturation, as well as edema 
(often thin tubes are used) and hyperaemia of the upper airway which cause frequent bleeding 
and make it difficult to visualize the vocal cords, especially in the presence of preeclampsia. In 
addition, decreased gastric motility and relaxation of esophageal sphincter tone increase the risk 
of aspiration. For all of the above, it is also recommended the use of muscle relaxants and rapid 
intubation sequence (SIR), as well as nasogastric tube placement (SNG) [12–14].
6.3. Cesarean perimortem 
Cesarean perimortem is defined as the birth of the fetus after maternal cardiac arrest. Birth is 
almost always accomplished through cesarean delivery, but assisted vaginal delivery is appro-
priate if the cervix is fully dilated and the neonate is at a low station and can be delivered within 
5 min of maternal cardiorespiratory collapse [15]. A review of published cases up to 2010 has 
showed that the cesarean perimortem led to a clear maternal survival benefit 31.7% [16].
The purpose of the cesarean perimortem is twofold. The first is facilitation of resuscitation, 
relieving aortocaval compression by emptying the uterus significantly improves resuscitative 
efforts. Second, early delivery of the baby, is accomplished with a decreased risk of perma-
nent neurological damage from anoxia.
It is contemplated within the “four-five rule” of obstetric stop, which consists of starting the cesar-
ean section 4 min after the maternal cardiac arrest so that he drinks be born within 5 min after the 
arrest spontaneous circulation and not later, especially when the cause is irreversible (e.g. abrupt), 
which in turn improves the maternal GC by 30% with autotransfusion of 500 ml. It is the most 
important consideration in the OP. According to Katz, 71% of babies surviving maternal cardio-
respiratory arrest with good neurologic outcome were removed in 5 min or less. Therefore, fetal 
extraction is considered as the “D” of cardiopulmonary resuscitation in the pregnant woman.
Sudden substantial improvement in hemodynamics with a return of pulse and blood pressure 
immediately after perimortem cesarean delivery has been observed.
There are three pathophysiological states (in relation to the uterus and navel): O Pregnancy < 
20 weeks, AU below navel: impaired hemodynamic compromise for the mother by the uterus, 
non-viable baby. No benefit of cesarean perimortem.
Or pregnancy of 20–23 weeks, AU up to 3 cm above the navel: possible hemodynamic involve-
ment of the mother by the uterus, probably not viable baby. Consider cesarean perimortem to 
save the life of the mother.
O pregnancy ≥ 24 weeks, AU at 4 cm above the navel: possible hemodynamic compromise 
exerted by the uterus, cesarean section perimortem is indicated during cardiopulmonary 
arrest to benefit the mother as well as the fetus. Consider not closing the abdominal incision 
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if cesarean section was necessary, to bind blood vessels as well as reduce the possibility of an 
abdominal compartment syndrome [2, 3, 6–10].
If the cesarean perimortem could not be performed by the 5-min mark, it was still advisable 
to prepare to evacuate the uterus while the resuscitation continued, infant survival has been 
seen even when delivery occurred > 5 min from the onset of maternal cardiac arrest. Neonatal 
survival was documented even when delivery occurred up to 30 min after the onset of mater-
nal cardiac arrest [17]. The procedure should be performed at the site of the maternal resusci-
tation. Time should not be wasted in moving the patient or waiting for surgical equipment or 
doing abdominal preparation [18]. The only equipment needed to start is a scalpel [5].
7. Other considerations
• Regarding the drugs used in a cardiorespiratory arrest, these do not differ in the pregnant 
patient, although it is recognized that the vasopressors could decrease the uterine blood flow, 
remember that the best possibility for the survival of the fetus is the survival of the mother.
• Regarding the energy used for defibrillation/cardioversion, pregnancy does not signifi-
cantly alter the electrical impedance of the chest wall and no deleterious effect of maternal 
defibrillation/cardioversion has been reported in newborns.
• Oxytocin and prostaglandins may be considered to correct uterine atony.
• In summary, an Obstetric Code (OC) is a situation in which a doctor can save two lives as 
long as resources are available and procedures are performed in less than 5 min [15, 19, 20].
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